It is understandable to want a straightforward answer about which weight-loss treatment is best. Comparisons online often focus on average trial results or price, but neither tells a clinician whether a medicine is suitable for you.
Mounjaro, Wegovy and Foundayo differ in active ingredient, how they act in the body and how they are taken. Wegovy is available in both weekly injection and daily tablet forms, while Foundayo is a separate once-daily oral GLP-1 treatment containing orforglipron. Availability may vary.
How do Mounjaro, Wegovy and Foundayo differ?
Mounjaro contains tirzepatide and acts on GIP and GLP-1 pathways. Wegovy injections and tablets contain semaglutide and act on the GLP-1 pathway. Foundayo contains orforglipron and is also a GLP-1 receptor agonist. Mounjaro and injectable Wegovy are used once weekly. Wegovy tablets are taken daily using a specific fasting routine, while Foundayo is taken once daily without food or water restrictions. The most appropriate option depends on safety, medical history, treatment response, current medicines, preferences and practical circumstances.
The treatment with the highest average weight loss is not automatically the right treatment for the person in front of us. We look at safety, medical history, other medicines, likely tolerance and whether the treatment will fit realistically into everyday life.
This is a treatment guide, not a prescribing decision.
Only a clinician who has reviewed your health information can advise which options may be appropriate.
An overview of the four options
-
Weekly injection
Mounjaro
Contains tirzepatide and acts on both GIP and GLP-1 receptors involved in appetite and blood-glucose regulation.
-
Weekly injection
Wegovy injection
Contains semaglutide, a GLP-1 receptor agonist, delivered using a pre-filled injection pen.
-
Daily tablet
Wegovy tablet
Contains semaglutide in an oral form that must be taken using a specific fasting routine to support absorption.
-
Daily tablet
Foundayo
Contains orforglipron, a once-daily oral GLP-1 receptor agonist that can be taken without food or water restrictions.
All four are prescription-only medicines used alongside nutrition, activity and wider weight-management support. None is intended as a quick or cosmetic weight-loss solution.
Mounjaro, Wegovy and Foundayo at a glance
| Feature | Mounjaro | Wegovy injection | Wegovy tablet | Foundayo |
|---|---|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide | Semaglutide | Orforglipron |
| How it acts | GIP and GLP-1 receptor agonist | GLP-1 receptor agonist | GLP-1 receptor agonist | GLP-1 receptor agonist |
| Format | Pre-filled injection pen | Pre-filled injection pen | Tablet swallowed whole | Tablet swallowed whole |
| Routine | Once weekly | Once weekly | Once daily after an overnight fast, followed by a waiting period before food, drink or other oral medicines | Once daily; may be taken with or without food and without water restrictions |
| May appeal to | People for whom tirzepatide is clinically suitable and a weekly injection is manageable | People for whom semaglutide is suitable and who prefer a weekly routine | People who prefer to avoid injections and can follow the daily fasting instructions consistently | People for whom orforglipron is clinically suitable, prefer an oral option and want a daily routine without fasting requirements |
| Key practical consideration | Weekly injection technique and storage | Weekly injection technique and storage | Daily adherence and correct timing are important for absorption | Daily adherence; suitability, interactions and tolerability still require clinical review |
The table describes broad differences only. It does not show every indication, contraindication, dose, side effect or interaction. Those details belong in the product information and your clinical assessment.
Trial results should not be compared as though they came from one identical study. Doses, treatment durations, participant groups and lifestyle support can differ, so headline percentages do not provide a like-for-like prediction of individual results.
Injection or tablet: which routine is easier?
The answer depends on what feels manageable in your daily life.
-
Weekly injections
A once-weekly routine may be easier to remember. The pens are designed for self-administration, but some people dislike needles or feel anxious about injection technique.
-
Daily Wegovy tablets
There is no injection, but the tablet must be taken correctly every day. It is swallowed whole on an empty stomach after fasting for at least eight hours, with a small amount of water. You then wait at least 30 minutes before eating, drinking or taking other oral medicines.
-
Daily Foundayo tablets
Foundayo is also taken once daily, but it does not require fasting and can be taken with or without food and without water restrictions. A regular daily routine is still important.
A tablet is therefore not automatically the simpler option. Wegovy tablets have a specific fasting and timing routine, whereas Foundayo can be taken once daily without food or water restrictions. Shift work, other medicines, breakfast routines, adherence and gastrointestinal symptoms may all affect practicality.
Detailed guide: Wegovy Tablets: What to Know About the Weight-Loss Pill
What affects clinical suitability?
Suitability is based on more than BMI or how much weight someone hopes to lose.
- your medical history and weight-related health risks;
- pregnancy, breastfeeding or plans for pregnancy;
- current medicines, including oral medicines and contraception;
- diabetes history and any diabetes treatment;
- previous pancreatitis, gastrointestinal or gallbladder problems;
- kidney or liver health where relevant;
- previous experience of weight-management medicines;
- side effects and ability to maintain nutrition and hydration;
- your preference for a weekly injection, a daily fasting routine or a daily tablet without food or water restrictions;
- medicine availability and whether treatment can be continued safely.
Tell your prescriber about every medicine you take.
These treatments can affect stomach emptying, and individual products have specific interaction and contraception advice. Choosing a tablet does not remove the need to review other medicines, timing considerations or your wider medical history.
Why the “best” treatment is not always the strongest, newest or cheapest
Clinical studies can compare average results across groups, but they cannot predict exactly how one individual will respond.
Tirzepatide has produced greater average weight loss than standard-dose semaglutide in some studies. Wegovy has established evidence in injectable and oral formats, while Foundayo offers a different once-daily oral GLP-1 option. These facts still do not create one universal winner, and results from separate trials should not be treated as direct like-for-like comparisons.
-
Safety
Can it be prescribed?
A medicine must first be appropriate for your health history and current treatment.
-
Tolerance
Can you take it comfortably?
A theoretically effective medicine is not useful if side effects prevent safe continuation.
-
Practicality
Can it fit your life?
Routine, availability, cost and correct administration affect whether treatment is sustainable.
The lowest price may also change by dose and over time. Use LIVVE’s current product and service pages for live pricing, availability and prescribing information rather than relying on an article that may become outdated.
Can you switch between Mounjaro, Wegovy and Foundayo?
Switching may be considered when a treatment is unsuitable, poorly tolerated, unavailable, unaffordable or not providing an appropriate response.
It is not a direct dose-for-dose exchange. A clinician needs to decide when the new medicine should start and which starting dose is appropriate.
Do not overlap Mounjaro, Wegovy or Foundayo.
Do not use two GLP-1-based weight-management treatments together or plan your own switch. Follow the timing given by your prescriber.
This article does not provide an individual switching schedule because recommendations depend on the treatments, doses, side effects and clinical circumstances involved.
Which treatment is best for menopause weight gain?
No treatment is selected solely because weight changed during perimenopause or menopause.
A LIVVE review can consider menopause symptoms, HRT, sleep, activity, body composition and metabolic health alongside the separate eligibility and safety criteria for weight-management medicine.
Read next: Mounjaro, Wegovy and HRT: Can They Be Used Together?
Why LIVVE uses clinician-led assessment
Your preferences matter, and you should understand the available choices. However, these are prescription medicines rather than products selected from a price list.
Before prescribing, a LIVVE clinician reviews your questionnaire and medical information, discusses your goals and concerns, and explains which options may be clinically suitable.
The clinician may recommend:
- one of the four options discussed in this article;
- a different treatment or route;
- remaining on a current treatment rather than switching;
- further information or medical review before prescribing;
- no prescription if treatment would not be safe or appropriate.
You are involved in the decision.
Clinician-led does not mean your preferences are ignored. It means your choice is considered within safe prescribing boundaries.
Where can I find prices, doses and current availability?
Product and service pages are the right place for information that changes frequently. They explain current pricing, available strengths, supply status and the consultation required before prescribing.
- View Mounjaro treatment information
- View Wegovy injection information
- View Wegovy tablet information
- View Foundayo tablet information
- Read more about LIVVE's weight-loss treatment service
This comparison article deliberately avoids repeating dose-by-dose product copy so the resource hub remains educational and the live treatment pages remain the source for changing commercial details.
For side-effect guidance: Managing Nausea, Constipation and Other Weight-Loss Treatment Side Effects
Not sure which treatment option may suit you?
LIVVE uses a clinician-led assessment to review your health, medicines, treatment history, preferences and goals before prescribing. Where treatment is appropriate, your clinician will explain the suitable options rather than expecting you to choose from a sales comparison chart.
Frequently asked questions
Is Mounjaro stronger than Wegovy?
Tirzepatide, the active ingredient in Mounjaro, has produced greater average weight loss than standard-dose semaglutide in some clinical studies. That does not mean Mounjaro is automatically the best treatment for every person. Suitability, tolerance, health history, current medicines and the ability to continue treatment all matter.
Are tablets easier than injections?
They may feel easier for someone who strongly prefers to avoid needles, but the two tablet options have different routines. Wegovy tablets require an overnight fast and a waiting period before food, drink or other oral medicines. Foundayo is taken once daily without food or water restrictions. A weekly injection may still be simpler for some people.
Can I switch between treatments?
A clinician may recommend a switch if treatment is not suitable, is poorly tolerated, is unavailable or no longer meets your needs. The timing and starting dose must be planned safely. Do not overlap Mounjaro, Wegovy or Foundayo, or switch without prescriber advice.
How is Foundayo different from Wegovy tablets?
Both are once-daily oral GLP-1 treatments, but they contain different active ingredients and have different administration requirements. Wegovy tablets contain semaglutide and require fasting and a waiting period around food, drink and other oral medicines. Foundayo contains orforglipron and can be taken with or without food and without water restrictions. Clinical suitability remains more important than convenience alone.
Which option is best for menopause weight gain?
There is no medicine specifically chosen simply because weight changed during menopause. Eligibility and suitability are assessed using your BMI, weight-related health risks, medical history, menopause symptoms, HRT, current medicines and personal circumstances.
Do I choose the treatment or does a clinician advise?
Your preferences are important, but these are prescription medicines. A LIVVE clinician reviews your assessment, explains suitable options and makes sure any prescription is clinically appropriate. Sometimes the treatment you initially prefer may not be the safest or most practical option.
